RXPHARMA_LIMITED - Accounts

RXPHARMA LIMITED - Company Information

Print Friendly Version

Company Registration No. 04457030 (England and Wales)

RXPHARMA LIMITED

UNAUDITED ABBREVIATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2016

RXPHARMA LIMITED

CONTENTS

Page

Abbreviated balance sheet

Notes to the abbreviated accounts

2 - 3

RXPHARMA LIMITED

ABBREVIATED BALANCE SHEET

AS AT

30 JUNE 2016

- 1 -

2016

2015

Notes

Fixed assets

Tangible assets

Current assets

Debtors

20,562

22,185

Cash at bank and in hand

3,416

9,281

23,978

31,466

Creditors: amounts falling due within one year

(70,878)

(113,358)

Net current liabilities

(46,900)

(81,892)

Total assets less current liabilities

(46,900)

(81,847)

Capital and reserves

Called up share capital

450

Other reserves

450

Profit and loss account

(47,800)

(82,747)

Shareholders' funds

(46,900)

(81,847)

For the financial year ended 30 June 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

Approved by the Board for issue on 31 March 2017

Mr P A Williams

Director

Company Registration No. 04457030

RXPHARMA LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS

FOR THE YEAR ENDED 30 JUNE 2016

- 2 -

Accounting policies

1.1

Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

The company is reliant upon the support of the director, who is also the owner, of the company. The director has confirmed his ongoing support of the company.

On this basis, the director considers it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would result from a withdrawal of the support of the director.

1.2

Compliance with accounting standards

The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).

1.3

Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.4

Patents

Patents are valued at cost less accumulated amortisation. Amortisation is calculated to write off the cost in equal annual instalments over their estimated useful lives.

1.5

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Plant and machinery

50% straight-line

Fixtures, fittings & equipment

25% straight line

RXPHARMA LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)

FOR THE YEAR ENDED 30 JUNE 2016

- 3 -

Fixed assets

Intangible assets

Tangible assets

Total

Cost

At 1 July 2015 & at 30 June 2016

50,000

54,334

104,334

Depreciation

At 1 July 2015

50,000

54,289

104,289

Charge for the year

At 30 June 2016

50,000

54,334

104,334

Net book value

At 30 June 2016

At 30 June 2015

Share capital

2016

2015

Allotted, called up and fully paid

450 Ordinary Shares of £1 each

450